Cargando...
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification
Accumulating evidence suggests that prostatic cancers represent a group of histologically and molecularly heterogeneous diseases with variable clinical courses. In accordance with the increased knowledge of their clinicopathologies and genetics, the World Health Organization (WHO) classification of...
Gardado en:
| Publicado en: | Oncotarget |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865702/ https://ncbi.nlm.nih.gov/pubmed/29581876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24515 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|